Showing results (1991-2000 of 3,086) with videos related to
Sort By:
Pageof 309
Drug Safety|May 23, 2012
Novel adverse events of bevacizumab in the US FDA adverse event reporting system database: a disproportionality analysisBehrooz K Shamloo, Pankdeep Chhabra, Andrew N Freedman, et al.Drug Safety|October 30, 2013
How well do various health outcome definitions identify appropriate cases in observational studies?Richard A Hansen, Michael D Gray, Brent I Fox, et al.Drug Safety|October 30, 2013
Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis systemG Niklas Norén, Tomas Bergvall, Patrick B Ryan, et al.Drug Safety|October 30, 2013
Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databasesMartijn J Schuemie, Rosa Gini, Preciosa M Coloma, et al.Drug Safety|October 30, 2013
The impact of drug and outcome prevalence on the feasibility and performance of analytical methods for a risk identification and analysis systemChristian G Reich, Patrick B Ryan, Marc A SuchardDrug Safety|June 1, 1997
Asthma mortality and antipsychotic or sedative use. What is the link?K S JosephDrug Safety|June 1, 1997
Epidemiology and relative toxicity of antidepressant drugs in overdoseJ A HenryDrug Safety|June 1, 1997
Preliminary risk-benefit analysis of ropivacaine in labour and following surgeryI CederholmDrug Safety|June 1, 1997
Antipsychotic use in pregnancy. What are the best treatment options?M Trixler, T TényiPageof 309